Vimian Pharma Holding AB is a Swedish AB, operating in the Economic activity was not specified by tax authority sector. Incorporated in 2017, the company has 0 employees and reported revenue of SEK 1.0k in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, äga och förvalta aktier och andelar i dotterbolag och intressebolag verksamma inom bland annat djurhälsovård och idka därmed förenlig verksamhet.
(no translation available)
Contact
Address
Email
gabriel.fitzgerald@fideliocapital.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
In its most recent annual report (2025), Vimian Pharma Holding AB reported revenue of SEK 1.0k. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of SEK 3.0k, and the EBITDA margin stood at -1,100%.
At the end of 2025, equity financed 98.5% of the balance sheet, and current assets covered short-term debt 0.4 times.
Frequently asked questions
What is the Org number of Vimian Pharma Holding AB?
Vimian Pharma Holding AB is registered with Bolagsverket / SCB under Org 5591336093.
What is the revenue of Vimian Pharma Holding AB?
Vimian Pharma Holding AB reported revenue of SEK 1.0k in 2025.
Who is the chairman of Vimian Pharma Holding AB?
Alireza Tajbakhsh chairs the board of Vimian Pharma Holding AB, in role since 2026.
